Philip R. Rice

Expressive Constructs, Inc. researches and develops antibody detection technologies. The company's products include diagnostic sensor for urinary tract infections and wound care systems that provide warning of emergent infections and promote healing. It was founded by Mitch Sanders in 1998 and is headquartered in Worcester, MA.

Cassidy Gold Corp. engages in the exploration and development of gold deposits. Its project include Kouroussa Gold Project located in Guinea. The company was founded on November 26, 1984 and is headquartered in Kamloops, Canada.

Nevaro Capital Corp. operates as a capital pool company. It invests in exchange-traded securities and in securities from private companies. The company was founded on November 13, 1986 and was headquartered in Vancouver, Canada.

Johnson & Johnson Consumer, Inc. manufactures health and skin care products. It offers wide variety of lotion, moisturizing cream, baby wash, shampoo and conditioner, baby powder and bath, hand and face wipes, soap, baby oil and cologne. The company was founded on March 8, 2016 and is headquartered in Skillman, NJ.

Cutanea Life Sciences, Inc. Develops and commercialises innovative dermatology related products. The company was founded in May 2005 and is headquartered in Wayne, PA.

Sherbrook SBK Sport Corp. designs, manufactures and distributes sporting goods and apparels. It offers apparel, goaltender composite and foam core hockey sticks, player and goaltender hockey protective equipment, and player and fantasy skates. The company was founded on October 12, 2006 and is headquartered in Sherbrooke, Canada

Part of GSK Plc, Smithkline Beckman Corp is a company that manufactures pharmaceutical products. The company is based in Philadelphia, PA. Smithkline Beckman was acquired by Smithkline Beecham Plc on July 27, 1989 for $16,082.37 million.

Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain.

RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT.

BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart.

Part of Global Roundtable Corp., Advanced Gold Technology, Inc. provides gold mining services. The company is based in Wilmington, DE. Advanced Gold Technology was acquired by Global Roundtable Corp. on December 09, 2010 for $0.02 million.

Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY.

Axosim, Inc. operates as a biotechnology company that develops nerve-on-a-chip platform. The company was founded by Lowry Curley and Michael Moore and is headquartered in New Orleans, LA.

Bioelectronica Corp. is a research-stage biotechnology company that specializes in building intelligent, digital tools for drug discovery, cell screening, and cell sorting. The company is based in Reno, NV. The company's platform technology combines computer vision, biochemical reagents, and consumer electronics to accelerate discovery. Bioelectronica was founded by Roger Chen and Jonathan Hull.

Ancilia Biosciences, Inc. is an American company that is developing virus-resistant live bacterial biotherapeutics to alter the gut microbiome and treat disease. Ancilia is based in the United States, and its founders and advisers include key scientific leaders across CRISPR and the virome. Ancilia's proprietary platform is being developed as an essential enabling technology that characterizes viral phages and leverages the natural function of CRISPR to produce a new class of live biotherapeutics with engineered immunity to key viral pathogens. The company has demonstrated proof of principle and filed key patents for the technology. The company was founded to overcome a potential obstacle to the success of LBPs, which is their failure to address the role of predatory viral phages in causing disease and limiting the ability of LBPs to engraft in the gut. The company was founded by Alexandra Sakatos, who has been the CEO since incorporation.